Search results
Results from the WOW.Com Content Network
The 2010 DePuy Hip Replacement Recall was instituted when DePuy Orthopaedics, Inc., a division of Johnson and Johnson, recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. [1] [2]
In many other countries, DePuy operates as a brand under the Johnson & Johnson Medical organization. [1] DePuy is currently the subject of more than 11,000 lawsuits related to its recall of faulty hip replacement systems, which lawyers and industry analysts estimate will cost parent company Johnson & Johnson billions of dollars to resolve. [2]
Johnson & Johnson. / 40.49861°N 74.44361°W / 40.49861; -74.44361. Johnson & Johnson ( J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones ...
Johnson & Johnson investors have had enough with the word "recall" recently. Between its massive over-the-counter children's medicines recall back in 2010 to its recent headache-inducing hip ...
Johnson & Johnson (NYSE: JNJ) is exploring a plan to offload liabilities from its Baby Powder litigation into a newly created business that would then seek bankruptcy protection, Reuters reports.
Johnson & Johnson CEO William Weldon (pictured) apologized to Congress Thursday for a series of issues that recently have beset the world's biggest health-products company, specifically the recall ...
In medical technologies, J&J's major franchises include interventional solutions, orthopedics, surgery, and vision. [1] Heart and Cardiac. Abiomed. Ear, nose and throat ( Acclarent) (2010–2024) Eustachian Tube Balloon Dilation System [2] Navigation Balloon Dilation System [3]
Johnson & Johnson (JNJ) shares are rebounding today, up nearly 1.5% to $65.51. The drugmaker is trying to recover from a rough week, when the Justice Department charged it with paying kickbacks to ...